Seismic Therapeutic Funding: $222M Raised, Series B (2024)
Seismic Therapeutic is a Biotech company. It has raised $222M in total funding. Latest round: Series B. Backed by Lightspeed Venture Partners.
Seismic Therapeutic funding overview
Seismic Therapeutic is a Biotech company. Seismic Therapeutic has raised $222M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Seismic Therapeutic runs through 2024; nothing later has been disclosed. Investors on record include Lightspeed Venture Partners.
Seismic Therapeutic at a glance
Total raised
$222M
Latest round
Series B
Latest round date
January 2024
Industry
Biotech
Notable investors
Lightspeed Venture Partners
Frequently asked about Seismic Therapeutic funding
How much has Seismic Therapeutic raised?
Seismic Therapeutic has raised $222M in total disclosed funding across the rounds on record.
Who has invested in Seismic Therapeutic?
Lightspeed Venture Partners are named among the investors backing Seismic Therapeutic.
What was the latest Seismic Therapeutic funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is Seismic Therapeutic based?
No headquarters location is disclosed for Seismic Therapeutic.
What sector does Seismic Therapeutic operate in?
Seismic Therapeutic is tracked under Biotech, with $222M in disclosed funding.
When did Seismic Therapeutic last raise?
The last disclosed Seismic Therapeutic round closed in January 2024 at Series B.
We update the Seismic Therapeutic record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
